Martingale Asset Management L P Artivion, Inc. Transaction History

Martingale Asset Management L P

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$16.76 - $23.74 $1.47 Million - $2.08 Million	-87,815 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$16.35 - $21.4 $1.69 Million - $2.21 Million	-103,500 Reduced 54.1%	87,815 $1.62 Million
Q1 2020 May 11, 2020	SELL	$14.66 - $30.57 $10,262 - $21,399	-700 Reduced 0.36%	191,315 $3.24 Million
Q4 2019 Feb 10, 2020	BUY	$22.45 - $27.09 $29,185 - $35,217	1,300 Added 0.68%	192,015 $5.2 Million
Q3 2019 Nov 13, 2019	BUY	$25.98 - $30.8 $1.63 Million - $1.94 Million	62,904 Added 49.22%	190,715 $5.18 Million
Q2 2019 Aug 13, 2019	BUY	$27.55 - $32.39 $2.53 Million - $2.97 Million	91,809 Added 255.01%	127,811 $0
Q1 2019 May 08, 2019	BUY	$25.85 - $30.47 $930,651 - $1.1 Million	36,002 New	36,002 $0

180

36M

33K

900

Ticker AORT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,316,100
Market Cap $1.23B
Description
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.